Progressive brain iron accumulation in neuroferritinopathy measured by the thalamic T2* relaxation rate

American Journal of Neuroradiology

Volumn 33, Issue 9, 2012, Pages 1810-1813

  McNeill, A ^a   Gorman, G ^b   Khan, A ^b   Horvath, R ^b   Blamire, A M ^b   Chinnery, Patrick F ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERRITIN LIGHT POLYPEPTIDE; POLYPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DYSTONIA; FEMALE; GENE MUTATION; HUMAN; MALE; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROFERRITINOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; RATING SCALE; SUBSTANTIA NIGRA; THALAMUS;

ADULT; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; IRON METABOLISM DISORDERS; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROAXONAL DYSTROPHIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THALAMUS;

EID: 84867801862     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3036     Document Type: Article

References (12)

1. Curtis AJ, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light chain polypeptide causes adult onset autosomal dominant basal ganglia disease. Nat Genet 2001;28:350-54 (Pubitemid 32702424)
2. Chinnery PF, Crompton DE, Birchall D, et al. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460insA mutation. Brain 2007;130:110-19 (Pubitemid 46026227)
3. Mancuso M, Davidzon G, Kurlan RM, et al. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol 2005;64:280-94 (Pubitemid 40489555)
4. Vidal R, Ghetti B, Takao M, et al. Intracellular ferritin accumulation in neuronal and extra-neuronal tissues characterises a neurodegenerative disorder associated with a mutation in the ferritin light polypeptide gene. J Neuropath Exp Neurol 2004;63:363-80 (Pubitemid 38429033)
5. McNeill A, Birchall D, Hayflick SY, et al. T2*and FSE MRI distinguish four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008;70:1614-19 (Pubitemid 351620317)
6. House MJ, St Pierre TG, Kowdley KV, et al. Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from Alzheimer's disease patients. Magn Reson Med 2007;57:172-80
7. Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999;210:759-67 (Pubitemid 29124039)
8. Jensen JH, Szulc K, Hu C, et al. Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn Reson Med 2009;61:481-85
9. Ordidge RJ, Gorell JM, Deniau JC, et al. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 1994;32:335-41 (Pubitemid 24274912)
10. Aquino D, Bizzi A, Grisoli M, et al. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009;1:165-72
11. Szumowski J, Bas E, Gaarder K, et al. Measurement of brain iron distribution in Hallevorden-Spatz syndrome. J Magn Reson Imaging 2010;31:482-89
12. Mittal S, Wu Z, Neelavalli J, et al. Susceptibility-weighted imaging: technical aspects and clinical applications. AJNR Am J Neuroradiol 2009;30:232-52